103 related articles for article (PubMed ID: 6373861)
1. Eruptive vascular tumors associated with chronic graft-versus-host disease.
Garnis S; Billick RC; Srolovitz H
J Am Acad Dermatol; 1984 May; 10(5 Pt 2):918-21. PubMed ID: 6373861
[TBL] [Abstract][Full Text] [Related]
2. Eruptive angiomatous lesions associated with graft-versus-host disease.
Adamski H; Le Gall F; Cartron L; Dauriac C; Lancien G; Wechsler J; Ollivier I; Lachgar S; Dosquet C; Coudert MC; Chevrant-Breton J
Br J Dermatol; 2003 Sep; 149(3):667-8. PubMed ID: 14511016
[No Abstract] [Full Text] [Related]
3. Endoscopic appearance of the colon and small intestine of a patient with hemorrhagic enteric graft-vs.-host disease.
Saito H; Oshimi K; Nagasako K; Yashiro K; Tanaka T; Toyoda C; Mizoguchi H
Dis Colon Rectum; 1990 Aug; 33(8):695-7. PubMed ID: 2376226
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous granulocytic sarcoma (chloroma) presenting as the first sign of relapse following autologous bone marrow transplantation for acute myeloid leukaemia.
Harris DW; Ostlere LS; Rustin MH
Br J Dermatol; 1992 Aug; 127(2):182-4. PubMed ID: 1390150
[TBL] [Abstract][Full Text] [Related]
5. A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment.
Li AW; Lalor LE; Bellodi Schmidt F; Luu M
Pediatr Dermatol; 2018 May; 35(3):e165-e169. PubMed ID: 29570823
[TBL] [Abstract][Full Text] [Related]
6. Nodular Sclerodermatous Chronic Cutaneous Graft-Versus-Host Disease (GvHD): A New Clinicopathological Variant of Cutaneous Sclerodermatous GvHD Resembling Nodular/Keloidal Scleroderma.
Prieto-Torres L; Boggio F; Gruber-Wackernagel A; Cerroni L
Am J Dermatopathol; 2017 Dec; 39(12):910-913. PubMed ID: 28475513
[TBL] [Abstract][Full Text] [Related]
7. Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases.
Chosidow O; Bagot M; Vernant JP; Roujeau JC; Cordonnier C; Kuentz M; Wechsler J; André C; Touraine R; Revuz J
J Am Acad Dermatol; 1992 Jan; 26(1):49-55. PubMed ID: 1732335
[TBL] [Abstract][Full Text] [Related]
8. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
9. [Allogeneic bone marrow transplantation in acute and chronic myeloid leukemia: role of conditioning and of graft-versus-host disease in the long-term maintenance of remission].
Bacigalupo A; Frassoni F; Van Lint MT; Occhini D; Gualandi F; Lamparelli T; Vitale V; Scarpati D; Clavio M; Marmont AM
Haematologica; 1989 Oct; 74(5 Suppl):425-32. PubMed ID: 2512226
[No Abstract] [Full Text] [Related]
10. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease.
Olson KA; West K; McCarthy PL
Pharmacotherapy; 2014 Jun; 34(6):e60-4. PubMed ID: 24700567
[TBL] [Abstract][Full Text] [Related]
11. Encouraging preliminary results in 12 patients with high-risk haematological malignancies by omitting graft-versus-host disease prophylaxis after allogeneic transplantation.
Fassas AB; Rapoport AP; Cottler-Fox M; Chen T; Tricot G
Br J Haematol; 2000 Nov; 111(2):662-7. PubMed ID: 11122119
[TBL] [Abstract][Full Text] [Related]
12. FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.
Huu DL; Matsushita T; Jin G; Hamaguchi Y; Hasegawa M; Takehara K; Fujimoto M
Arthritis Rheum; 2013 Jun; 65(6):1624-35. PubMed ID: 23508350
[TBL] [Abstract][Full Text] [Related]
13. [GvH reaction and bone marrow morphology following allogenic bone marrow transplantation].
Heymer B; Krüger G; Arnold R; Schmeiser T; Friedrich W; Kubanek B; Heimpel H
Verh Dtsch Ges Pathol; 1983; 67():367-71. PubMed ID: 6364604
[No Abstract] [Full Text] [Related]
14. Vanishing bile duct syndrome after allogeneic bone marrow transplantation: is it the end of the road?
Bakanay ŞM; Bilgin AU; Bektaş M; Idilman R; Erden E; Arat M; Arslan Ö
Turk J Gastroenterol; 2013; 24(4):359-62. PubMed ID: 24254270
[TBL] [Abstract][Full Text] [Related]
15. Peyronie's disease as a complication of chronic graft versus host disease.
Grigg AP; Underhill C; Russell J; Sale G
Hematology; 2002 Jun; 7(3):165-8. PubMed ID: 12243979
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with steroids of upper gastrointestinal acute graft vs. host disease after hematopoietic stem cell transplantation.
Nishi T; Okazaki K; Fujii S; Uchida K; Uose S; Nakase H; Ohana M; Nishihara T; Chiba T
Endoscopy; 2001 Nov; 33(11):985-7. PubMed ID: 11668409
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
18. Eruptive angiomas associated with graft-versus-host disease.
Soo JK; Mortimer PS
Br J Dermatol; 2006 Feb; 154(2):376-8. PubMed ID: 16433816
[No Abstract] [Full Text] [Related]
19. Chronic graft-versus-host disease and non-melanoma skin cancer in children: report of two cases.
Borroni RG; Vassallo C; Ciocca O; Castello M; Brazzelli V; Zecca M; Locatelli F; Borroni G
Acta Derm Venereol; 2008; 88(6):623. PubMed ID: 19002353
[No Abstract] [Full Text] [Related]
20. Graft-vs-host disease.
Tran K; Kaplan J; Kamino H; Latkowski JA
Dermatol Online J; 2013 Dec; 19(12):20710. PubMed ID: 24365001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
